| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.17B | — | +34.3% |
| Cost of Revenue | $1.62B | — | +36.4% |
| Gross Profit | $1.55B | — | +32.2% |
| R&D Expense | $437.0M | — | +15.9% |
| SG&A Expense | $115.0M | — | +5.5% |
| Operating Income | $382.0M | — | +88.2% |
| Income Tax | -$53.0M | — | +39.8% |
| Net Income | -$581.0M | — | +14.8% |
| EPS (Basic) | -$0.45 | — | +15.1% |
| EPS (Diluted) | -$0.45 | — | +15.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.85B | +19.6% | +41.2% |
| Short-term Investments | $3.90B | -8.0% | -7.4% |
| Accounts Receivable | $449.0M | -10.2% | +51.2% |
| Current Assets | $8.49B | +2.4% | +14.1% |
| Total Assets | $14.12B | -7.0% | +5.4% |
| Current Liabilities | $1.37B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $481.0M | — | +31.1% |
| Capital Expenditures | $5.0M | — | +25.0% |
| Investing Cash Flow | $310.0M | — | +150.1% |
| Financing Cash Flow | -$485.0M | — | -922.0% |
| Free Cash Flow | $476.0M | — | +31.1% |
| -31.8% |
| Stockholders' Equity | $12.50B | -7.2% | +13.1% |